Novel thermo-sensitive core-shell nanoparticles for targeted paclitaxel delivery.
Novel thermo-sensitive nanoparticles self-assembled from poly(N,N-diethylacrylamide-co-acrylamide)-block-poly(gamma-benzyl L-glutamate) were designed for targeted drug delivery in localized hyperthermia. The lower critical solution temperature (LCST) of nanoparticles was adjusted to a level between physiological body temperature (37 degrees C) and that used in local hyperthermia (about 43 degrees C). The temperature-dependent performances of the core-shell nanoparticles were systemically studied by nuclear magnetic resonance (NMR), circular dichroism (CD), fluorescence spectroscopy, dynamic light scattering (DLS), and atom force microscopy (AFM). The mean diameter of the nanoparticles increased slightly from 110 to 129 nm when paclitaxel (PTX), a poorly water-soluble anti-tumor drug, was encapsulated. A stability study in bovine serum albumin (BSA) solution indicated that the PTX loaded nanoparticles may have a long circulation time under physiological environments as the LCST was above physiological body temperature and the shell remained hydrophilic at 37 degrees C. The PTX release profiles showed thermo-sensitive controlled behavior. The proliferation inhibiting activity of PTX loaded nanoparticles was evaluated against Hela cells in vitro, compared with Taxol (a formulation of paclitaxel dissolved in Cremophor EL and ethanol). The cytotoxicity of PTX loaded nanoparticles increased obviously when hyperthermia was performed. The nanoparticles synthesized here could be an ideal candidate for thermal triggered anti-tumor PTX delivery system.
The First Affiliated Hospital, Sun Yat Sen University, Guangzhou 510080, People's Republic of China.
Yuanpei
Y
Li
Shirong
S
Pan
Wei
W
Zhang
Zhuo
Z
Du
D000970:Antineoplastic Agents / Q000494:pharmacology*; D004304:Dosage Forms; D006367:HeLa Cells; D006801:Humans; D053758:Nanoparticles; D017239:Paclitaxel / Q000494:pharmacology*; D013696:Temperature
D000970:Antineoplastic Agents; D004304:Dosage Forms; D017239:Paclitaxel